BUSINESS● LOWSep 14 · Sep 14, 2026, 9:26 AM
Ozempic-maker Novo Nordisk slims down to ‘Novo’
South China Morning Post · western europe
Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced on Monday a name change to just Novo, hoping it will be more “memorable and relevant” for clients. The rebrand comes ahead of a strategic presentation on September 21, when executives are to lay out their plan for “a faster, more competitive and increasingly consumer-driven market”. The company is battling fierce competition in the anti-obesity sector, where its hugely successful Ozempic and...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowThe green hydrogen race in the Maghreb: is Morocco still ahead?Jeune AfriqueBUSINESS17m agoAnthropic co-founder Clark projects U.S. GDP to hit $44T by 2030 thanks to AISeeking Alpha Tech